Online weight loss treatment in Delaware
Surfbound connects eligible adults in Delaware with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in Delaware?
Yes. Eligible adults across Delaware can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in Delaware reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your Delaware address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The First State · Mid-Atlantic region. A small state with limited in-person weight-loss specialty options. Quick online access statewide — no specialist-shortage barrier.
Coverage across Delaware
Care is delivered entirely online across Delaware, so you can start from anywhere in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to Delaware
Prescriptions for Delaware patients are routed to a licensed compounding pharmacy. Dispatch follows provider approval, and delivery time varies with distance across the Mid-Atlantic region, from Wilmington, Dover, Newark to rural addresses, plus pharmacy and carrier schedules. Tracking is provided by email.
What's included in every Delaware plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
Delaware coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in Delaware. The Delaware provider access & process page covers the clinical steps in detail.
Care is delivered online across Delaware, so you can start from anywhere in the state — no in-person visit is required.
The Delaware telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in Delaware. You complete a health intake online, and a licensed provider credentialed in Delaware reviews your information remotely.
Delaware permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in Delaware may review a Delaware patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in Delaware” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active Delaware license issued by the Delaware Board of Medical Licensure and Discipline, and any pharmacy filling your prescription must be licensed in Delaware. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in Delaware” section on this page.
Delaware residents pay $169/mo for compounded semaglutide or $219/mo for compounded tirzepatide, provider review included. Compounded medications are not FDA-approved, and the price is displayed before you pay.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
No. A prescription for a Delaware patient is issued only when a licensed Delaware provider determines treatment is medically appropriate after reviewing the health intake.
Yes. Delaware patients already taking a GLP-1 can request a dose match when clinically appropriate. Sign up and use the doctor-notes field at the end of the form to list your current medication and dose, and whether you want to stay at that dose or discuss increasing it. Your Delaware-licensed clinician reviews the request and determines the prescription. No written quote is required to switch.
The GLP-1 total-cost calculator compares equal monthly recurring cost — membership, shipping and dose surcharges for any plan — against Surfbound's flat Delaware rate, so Delaware residents compare complete costs rather than a headline number.
Compounded semaglutide is one of the two GLP-1 options available across Delaware, priced flat each month with the provider review included. Nothing ships unless a Delaware-licensed provider approves treatment. It is not an FDA-approved medication.
Compounded tirzepatide is part of the Delaware offering, priced flat each month with delivery included. Whether it is the right option is a clinical decision made by a Delaware-licensed provider, and it is not an FDA-approved medication.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and Delaware residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the Delaware-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in Delaware. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed Delaware provider approves your medication. A small state with limited in-person weight-loss specialty options.
Yes. Delaware residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed Delaware provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across Delaware with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A Delaware-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. Delaware residents complete a short online intake on their own schedule, and a Delaware-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. A small state with limited in-person weight-loss specialty options. Quick online access statewide — no specialist-shortage barrier.
Yes. Men across Delaware begin with a private online intake, a licensed Delaware provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches Delaware residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in Delaware
What governs a provider treating a Delaware patient online, and where you can check it yourself.
State medical board
Delaware Board of Medical Licensure and DisciplineDelaware Board of Medical Licensure and Discipline licenses the providers who review Delaware intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
Delaware Code Title 24, Chapter 17Opens the official Delaware code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active Delaware license to evaluate or treat a patient who is physically located in Delaware. Every Delaware intake is routed to a provider credentialed in Delaware, and a prescription is issued only when that provider determines treatment is medically appropriate.
Under Delaware board rules, a treatment relationship cannot be established through an online form alone. Intake checkout routes you to a brief live video or telephone consultation with a licensed provider before the clinical evaluation is complete.
State Medical Board Disclosure: Under Delaware law, a telehealth treatment relationship cannot be established solely through an online form or questionnaire. To complete your clinical evaluation, you will be automatically routed to a brief live video or telephonic consultation with a licensed medical provider following intake checkout.
Surfbound is an online service. We do not have physical offices in Delaware. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in Delaware and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official Delaware state government agency. Provider licensure in Delaware is governed by the Delaware Board of Medical Licensure and Discipline.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.